These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
☒
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT OF 1934
|
|
|
|
|
|
For the
quarterly period ended May 31, 2019
|
|
☐
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT OF 1934
|
|
|
|
|
|
For the
transition period from ___________ to __________
|
|
Loop Industries, Inc.
|
|
(Exact
name of Registrant as specified in its charter)
|
|
Nevada
|
|
27-2094706
|
|
(State
or other jurisdiction of incorporation or
organization)
|
|
(I.R.S.
Employer Identification No.)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
Common
Stock
|
LOOP
|
Nasdaq
Global Market
|
|
Large accelerated
filer
|
☐
|
Accelerated
filer
|
☒
|
|
Non-accelerated
filer
|
☐
|
Smaller reporting
company
|
☒
|
|
|
|
Emerging growth
company
|
☐
|
|
|
|
|
|
|
|
|
|
Financial
Statements
|
4
|
|
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
5
|
|
|
Quantitative
and Qualitative Disclosures About Market Risk
|
13
|
|
|
Controls
and Procedures
|
14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Legal
Proceedings
|
15
|
|
|
Risk
Factors
|
1
5
|
|
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
16
|
|
|
Defaults
Upon Senior Securities
|
16
|
|
|
Mine
Safety Disclosures
|
16
|
|
|
Other
Information
|
16
|
|
|
Exhibits
|
17
|
|
|
|
|
|
|
|
Signatures
|
18
|
|
Contents
|
Page(s)
|
|
|
|
|
Condensed consolidated balance sheets as at May 31, 2019 and
February 28, 2019 (Unaudited)
|
F‑2
|
|
|
|
|
Condensed consolidated statements of operations and comprehensive
loss for the three months ended
|
F‑3
|
|
May 31, 2019 and 2018 (Unaudited)
|
|
|
|
|
|
Condensed consolidated statement of changes in stockholders’
equity for the three months ended
|
F‑4
|
|
May 31, 2019 and 2018 (Unaudited)
|
|
|
|
|
|
Condensed consolidated statement of cash flows for the three months
ended May 31, 2019 and 2018 (Unaudited)
|
F‑6
|
|
|
|
|
Notes to the condensed
consolidated financial statements (Unaudited)
|
F‑7
|
|
|
May
31,
2019
|
February
28,
2019
|
|
|
|
|
|
Assets
|
|
|
|
Current
assets
|
|
|
|
Cash
(Note 17)
|
$
6,971,613
|
$
5,833,390
|
|
Sales
tax, tax credits and other receivables (Note 3)
|
741,993
|
599,000
|
|
Prepaid
expenses
|
176,309
|
226,521
|
|
Total
current assets
|
7,889,915
|
6,658,911
|
|
Investment
in joint venture (Note 8)
|
500,000
|
-
|
|
Property,
plant and equipment, net (Note 4)
|
6,005,335
|
5,371,263
|
|
Intangible assets,
net (Note 5)
|
146,112
|
127,672
|
|
Total
assets
|
$
14,541,362
|
$
12,157,846
|
|
|
|
|
|
Liabilities and Stockholders' Equity
|
|
|
|
Current
liabilities
|
|
|
|
Accounts
payable and accrued liabilities (Notes 7)
|
$
3,103,159
|
$
2,670,233
|
|
Convertible
notes (Note 10)
|
3,653,549
|
5,636,172
|
|
Warrants
(Note 10)
|
-
|
219,531
|
|
Current
portion of long-term debt (Note 9)
|
51,748
|
53,155
|
|
Total
current liabilities
|
6,808,456
|
8,579,091
|
|
Long-term
debt (Note 9)
|
914,221
|
952,363
|
|
Total
liabilities
|
7,722,677
|
9,531,454
|
|
|
|
|
|
Stockholders' Equity
|
|
|
|
Series
A Preferred stock par value $0.0001; 25,000,000 shares authorized;
one share issued and outstanding (Note 11)
|
-
|
-
|
|
Common stock par value $0.0001: 250,000,000 shares
au
thorized; 34,875, 032 shares issued and outstanding
(February 28, 2019 – 33, 805,706) (Note 11)
|
3,488
|
3,381
|
|
Additional
paid-in capital
|
46,536,157
|
38,966,208
|
|
Additional paid-in
capital – Warrants (Note 10)
|
1,074,633
|
757,704
|
|
Additional paid-in
capital – Beneficial conversion feature (Note
10)
|
1,200,915
|
1,200,915
|
|
Common stock
issuable, 1,000,000 shares (Note 11)
|
800,000
|
800,000
|
|
Accumulated
deficit
|
(42,366,142
)
|
(38,811,592
)
|
|
Accumulated
other comprehensive loss
|
(430,366
)
|
(290,224
)
|
|
Total
stockholders' equity
|
6,818,685
|
2,626,392
|
|
Total
liabilities and stockholders' equity
|
$
14,541,362
|
$
12,157,846
|
|
|
|
|
|
|
|
|
|
|
Three
Months Ended May 31,
|
|
|
|
2019
|
2018
|
|
Revenue
|
$
-
|
$
-
|
|
|
|
|
|
Operating
Expenses -
|
|
|
|
Research
and development, net (Note 12)
|
997,861
|
1,066,079
|
|
General
and administrative (Note 12)
|
1,902,630
|
2,355,550
|
|
Depreciation
and amortization (Notes 4 and 5)
|
164,336
|
101,069
|
|
Interest
and other finance costs (Note 15)
|
501,849
|
12,913
|
|
Foreign
exchange (gain)
|
(12,126
)
|
(6,081
)
|
|
Total
operating expenses
|
3,554,550
|
3,529,530
)
|
|
|
|
|
|
Net
loss
|
(3,554,550
)
|
(3,529,530
)
|
|
|
|
|
|
Other
comprehensive loss -
|
|
|
|
Foreign
currency translation adjustment
|
(140,142
)
|
(52,268
)
|
|
Comprehensive
loss
|
$
(3,694,692
)
|
$
(3,581,798
)
|
|
Loss
per share
|
|
|
|
Basic
and diluted
|
$
(0.11
)
|
$
(0.11
)
|
|
Weighted
average common shares outstanding
|
|
|
|
Basic
and diluted
|
34,714,510
|
33,140,148
|
|
|
|
Three
Months Ended May 31, 2018
|
|||||||||
|
|
Common
stock
|
Preferred
stock
|
|
|
|
|
|
|
|
||
|
|
par
value $0.0001
|
par
value $0.0001
|
|
|
|
|
|
|
|
||
|
|
Number
of Shares
|
Amount
|
Number
of Shares
|
Amount
|
Additional
Paid-in Capital
|
Additional
Paid-in Capital - Warrants
|
Additional
Paid-in Capital – Beneficial Conversion
Feature
|
Common
Stock Issuable
|
Accumulated
Deficit
|
Accumulated
Other Comprehensive Income (Loss)
|
Total
Stockholders' Equity
|
|
Balance,
February 28, 2018
|
33,751,088
|
$
3,376
|
1
|
$
-
|
$
30,964,970
|
$
-
|
$
-
|
$
800,000
|
$
(21,275,181
)
|
$
(169,100
)
|
$
10,324,065
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of shares upon cashless exercise of warrants
|
18,821
|
2
|
-
|
-
|
(2
)
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Issuance
of shares upon vesting of restricted stock units
|
35,797
|
3
|
-
|
-
|
(3
)
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Warrants
issued for services
|
-
|
-
|
-
|
-
|
978,025
|
-
|
-
|
-
|
-
|
-
|
978,025
|
|
Restricted
stock units issued for services
|
-
|
-
|
-
|
-
|
207,644
|
-
|
-
|
-
|
-
|
-
|
207,644
|
|
Foreign
currency translation
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(52,268
)
|
(52,268
)
|
|
Net
loss
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(3,529,530
)
|
-
|
(3,529,530
)
|
|
Balance, May 31, 2018
|
33,805,706
|
$
3,381
|
1
|
$
-
|
$
32,150,634
|
$
-
|
$
-
|
$
800,000
|
$
(24,804,711
)
|
$
(221,368
)
|
$
7,927,936
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three
Months Ended May 31, 2019
|
|||||||||
|
|
Common
stock
|
Preferred
stock
|
|
|
|
|
|
|
|
||
|
|
par
value $0.0001
|
par
value $0.0001
|
|
|
|
|
|
|
|
||
|
|
Number
of Shares
|
Amount
|
Number
of Shares
|
Amount
|
Additional
Paid-in Capital
|
Additional
Paid-in Capital - Warrants
|
Additional
Paid-in Capital – Beneficial Conversion
Feature
|
Common
Stock Issuable
|
Accumulated
Deficit
|
Accumulated
Other Comprehensive (Loss)
|
Total
Stockholders' Equity
|
|
Balance,
February 28, 2019
|
33,805,706
|
$
3,381
|
1
|
$
-
|
$
38,966,208
|
$
757,704
|
$
1,200,915
|
$
800,000
|
$
(38,811,592
)
|
$
(290,224
)
|
$
2,626,392
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of common shares for cash, net of share issuance costs (Note
11)
|
600,000
|
60
|
-
|
-
|
4,266,725
|
-
|
-
|
-
|
-
|
-
|
4,266,785
|
|
Issuance
of shares for legal settlement (Note 15)
|
150,000
|
15
|
-
|
-
|
(15
)
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Issuance
of shares upon conversion of Convertible notes (Note
10)
|
319,326
|
32
|
-
|
-
|
2,372,549
|
316,929
|
-
|
-
|
-
|
-
|
2,689,510
|
|
Stock
options issued for services (Note 12)
|
-
|
-
|
-
|
-
|
575,513
|
-
|
-
|
-
|
-
|
-
|
575,513
|
|
Restricted
stock units issued for services (Note 12)
|
-
|
-
|
-
|
-
|
355,177
|
-
|
-
|
-
|
-
|
-
|
355,177
|
|
Foreign
currency translation
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(140,142
)
|
(140,142
)
|
|
Net
loss
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(3,554,550
)
|
-
|
(3,554,550
)
|
|
Balance, May 31, 2019
|
34,875,032
|
$
3,488
|
1
|
$
-
|
$
46,536,157
|
$
1,074,633
|
$
1,200,915
|
$
800,000
|
$
(42,366,142
)
|
$
(430,366
)
|
$
6,818,685
|
|
|
Three
Months Ended May 31,
|
|
|
|
2019
|
2018
|
|
Cash Flows from Operating Activities
|
|
|
|
Net
loss
|
$
(3,554,550
)
|
$
(3,529,530
)
|
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
|
|
|
Depreciation
and amortization
|
164,336
|
101,069
|
|
Stock-based
compensation expense
|
930,690
|
1,185,669
|
|
Accrued
interest
|
117,433
|
-
|
|
Loss
on revaluation of warrants
|
8,483
|
-
|
|
Debt
accretion
|
583,727
|
-
|
|
Deferred
financing costs
|
46,442
|
-
|
|
Gain
on conversion of convertible notes
|
(268,730
)
|
-
|
|
Changes
in operating assets and liabilities:
|
|
|
|
Sales
tax and tax credits receivable
|
(158,954
)
|
53,699
|
|
Prepaid
expenses
|
49,136
|
239,669
|
|
Accounts
payable and accrued liabilities
|
(5,366
)
|
(221,637
)
|
|
Net
cash used in operating activities
|
(2,087,353
)
|
(2,171,061
)
|
|
|
|
|
|
Cash Flows from Investing Activities
|
|
|
|
Investment
in joint venture
|
(500,000
)
|
-
|
|
Additions
to property, plant and equipment
|
(470,545
)
|
(585,958
)
|
|
Additions
to intangible assets
|
(24,811
)
|
(6,358
)
|
|
Net
cash used in investing activities
|
(995,356
)
|
(592,316
)
|
|
|
|
|
|
Cash Flows from Financing Activities
|
|
|
|
Proceeds
from sale of common shares
|
5,130,000
|
-
|
|
Share
issuance costs
|
(863,216
)
|
-
|
|
Repayment
of long-term debt
|
(13,057
)
|
(13,514
)
|
|
Net
cash (used) provided by financing activities
|
4,253,727
|
(13,514
)
|
|
|
|
|
|
Effect
of exchange rate changes
|
(32,796
)
|
(17,807
)
|
|
Net
change in cash
|
1,138,222
|
(2,794,698
)
|
|
Cash,
beginning of period
|
5,833,390
|
8,149,713
|
|
Cash,
end of period
|
$
6,971,612
|
$
5,355,015
|
|
|
|
|
|
Supplemental Disclosure of Cash Flow Information:
|
|
|
|
Income
tax paid
|
$
-
|
$
-
|
|
Interest
paid
|
$
14,488
|
$
13,037
|
|
|
May
31,
2019
|
February
28,
2019
|
|
Sales
tax
|
$
222,215
|
$
82,992
|
|
Research and
development tax credits
|
455,564
|
410,997
|
|
Other
receivables
|
64,214
|
105,011
|
|
|
$
741,993
|
$
599,000
|
|
|
As at May 31,
2019
|
||
|
|
Cost
|
Accumulated
depreciation
|
Net book
value
|
|
Building
|
$
1,832,840
|
$
(82,178
)
|
$
1,750,661
|
|
Land
|
226,540
|
-
|
226,540
|
|
Building
Improvements
|
373,823
|
(122,274
)
|
251,549
|
|
Machinery and
equipment
|
4,650,026
|
(935,568
)
|
3,714,458
|
|
Office equipment
and furniture
|
113,989
|
(51,863
)
|
62,126
|
|
Balances, end of
period
|
$
7,197,218
|
$
(1,191,883
)
|
$
6,005,335
|
|
|
|
|
|
|
|
As at February 28,
2019
|
||
|
|
Cost
|
Accumulated
depreciation
|
Net book
value
|
|
Building
|
$
1,882,665
|
$
(68,596
)
|
$
1,814,069
|
|
Land
|
232,699
|
-
|
232,699
|
|
Building
Improvements
|
383,985
|
(119,889
)
|
264,096
|
|
Machinery and
equipment
|
3,834,338
|
(841,236
)
|
2,993,102
|
|
Office equipment
and furniture
|
117,088
|
(49,791
)
|
67,297
|
|
Balances, end of
period
|
$
6,450,775
|
$
(1,079,512
)
|
$
5,371,263
|
|
|
As at May
31,
2019
|
As at February
28,
2019
|
|
|
|
|
|
Intangible assets,
at cost - beginning of period
|
$
127,672
|
$
533,369
|
|
Intangible assets,
accumulated depreciation – beginning of period
|
-
|
(200,629
)
|
|
|
127,672
|
332,740
|
|
|
|
|
|
Add: Additions in
the period
|
24,811
|
153,477
|
|
Deduct:
Amortization of intangibles
|
(3,015
)
|
(59,851
)
|
|
Deduct: Impairment
of intangibles
|
-
|
(298,694
)
|
|
Add (deduct):
Foreign exchange effect
|
(3,356
)
|
-
|
|
|
$
146,112
|
$
127,672
|
|
|
Fair Value Measurements as at May 31, 2019
|
||
|
|
Carrying
Amount
|
Fair
Value
|
Level in the
hierarchy
|
|
Instruments
measured at fair value:
|
$
-
|
$
-
|
-
|
|
|
|
|
|
|
Instruments
measured at amortized cost:
|
|
|
|
|
Long-term
debt
|
965,969
|
965,969
|
Level 2
|
|
Convertible
notes (Second Issuance)
|
$
3,556,249
|
$
4,900,000
|
Level 2
|
|
|
Fair Value
Measurements at February 28, 2019
|
||
|
|
Carrying
Amount
|
Fair
Value
|
Level in the
hierarchy
|
|
Instruments
measured at fair value:
|
|
|
|
|
Warrants
(First Issuance)
|
$
219,531
|
$
219,531
|
Level
3
|
|
|
|
|
|
|
Instruments
measured at amortized cost:
|
|
|
|
|
Long-term
debt
|
1,005,518
|
1,005,518
|
Level
2
|
|
Convertible
notes (First Issuance)
|
2,495,636
|
2,650,000
|
Level
2
|
|
Convertible
notes (Second Issuance)
|
$
3,126,886
|
$
3,150,000
|
Level
2
|
|
|
May
31,
2019
|
February
28,
2019
|
|
Trade accounts
payable
|
$
2,086,412
|
$
1,784,362
|
|
Accrued
liabilities
|
555,287
|
520,671
|
|
Accrued
bonuses
|
461,460
|
365,200
|
|
|
$
3,103,159
|
$
2,670,233
|
|
|
May
31,
2019
|
February
28,
2019
|
|
Instalment
loan
|
$
965,969
|
$
1,005,518
|
|
Less current
portion
|
51,748
|
53,155
|
|
Non-current
portion
|
$
914,221
|
$
952,363
|
|
Years ending
February 28,
|
Amount
|
|
2020
|
$
38,811
|
|
2021
|
51,748
|
|
2022
|
51,748
|
|
2023
|
51,748
|
|
2024
|
51,748
|
|
Thereafter
|
720,166
|
|
Total
|
$
965,969
|
|
|
May 31,
2019
|
February 28,
2019
|
Issue
Date
|
|
November 2018
Convertible Notes – Liability
|
-
|
$
2,495,636
|
$
2,495,636
|
|
Accrued interest
– Liability
|
-
|
60,793
|
-
|
|
Deferred financing
costs
|
-
|
(26,557
)
|
(63,738
)
|
|
Total
|
-
|
2,529,872
|
2,431,898
|
|
|
|
|
|
|
November 2018
Warrants – Liability
|
-
|
$
219,531
|
$
154,364
|
|
|
May 31,
2019
|
February 28,
2019
|
Issue
Date
|
|
January 2019
Convertible Notes – Liability
|
3,556,249
|
$
3,126,886
|
$
2,941,381
|
|
Accrued interest
– Liability
|
147,011
|
49,011
|
-
|
|
Deferred financing
costs
|
(49,711
)
|
(69,597
)
|
(79,539
)
|
|
|
3,653,549
|
3,106,300
|
2,861,842
|
|
|
|
|
|
|
January 2019
Beneficial Conversion Option – Equity
|
1,200,915
|
1,200,915
|
1,200,915
|
|
|
|
|
|
|
January 2019
Warrants – Equity
|
$
757,704
|
$
757,704
|
$
757,704
|
|
For
the period ended May 31, 2019
|
Number of
shares
|
Amount
|
|
Balance, February
28, 2019
|
33,805,706
|
$
3,381
|
|
Issuance of shares
for cash
|
600,000
|
60
|
|
Issuance of shares
upon settlement of legal matter
|
150,000
|
15
|
|
Issuance of shares
upon conversion of Convertible notes
|
319,326
|
32
|
|
Balance, May 31,
2019
|
34,875,032
|
$
3,488
|
|
For
the period ended May 31, 2018
|
Number of
shares
|
Amount
|
|
Balance, February
28, 2018
|
33,751,088
|
$
3,376
|
|
Cashless exercise
of stock options
|
18,821
|
2
|
|
Issuance of shares
upon vesting of restricted stock units
|
35,797
|
3
|
|
Balance, May 31,
2018
|
33,805,706
|
$
3,381
|
|
(i)
|
On
March 1, 2019, the Company sold 600,000 shares of its common stock
at an offering price of $8.55 per share in a registered direct
offering, for gross proceeds of $5,130,000;
|
|
(ii)
|
On
March 8, 2019 and March 11, 2019, the Company issued 150,000 shares
of its common stock in settlement of a legal matter;
|
|
(iii)
|
On
April 9, 2019, the Company converted Convertible notes with a face
value of $2,650,000 plus accrued interest of $80,241 at a
conversion price of $8.55, into 319, 326 common
shares.
|
|
|
2019
|
2018
|
||
|
|
Number of stock
options
|
Weighted average
exercise price
|
Number of stock
options
|
Weighted average
exercise price
|
|
Outstanding,
beginning of period
|
1,962,400
|
$
7.53
|
2,374,581
|
$
7.99
|
|
Granted
|
-
|
-
|
-
|
-
|
|
Exercised
|
-
|
-
|
(20,000
)
|
0.80
|
|
Forfeited
|
(10,010
)
|
8.75
|
(100,000
)
|
5.25
|
|
Expired
|
(260,417
)
|
13.89
|
-
|
-
|
|
Outstanding, end of
period
|
1,691,973
|
$
6.60
|
2,254,581
|
$
8.17
|
|
Exercisable, end of
period
|
914,998
|
$
6.10
|
926,249
|
$
6.61
|
|
|
2019
|
2018
|
||
|
Exercise
price
|
Number of stock
options outstanding
|
Weighted average
remaining life (yrs.)
|
Number of stock
options outstanding
|
Weighted average
remaining life (yrs.)
|
|
$
0.80
|
582,081
|
6.51
|
582,081
|
7.50
|
|
$
3.00
|
-
|
-
|
12,500
|
0.01
|
|
$
5.25
|
380,000
|
8.24
|
430,000
|
8.19
|
|
$
8.75
|
16,683
|
0.04
|
-
|
-
|
|
$
11.52
|
13,209
|
0.04
|
-
|
-
|
|
$
12.00
|
700,000
|
8.29
|
700,000
|
9.29
|
|
$
13.49
|
-
|
-
|
250,000
|
9.38
|
|
$
13.89
|
-
|
-
|
280,000
|
9.44
|
|
Outstanding, end of
period
|
1,691,973
|
7.52
|
2,254,581
|
8.60
|
|
Exercisable, end of
period
|
914,998
|
7.54
|
926,249
|
7.96
|
|
|
2019
|
2018
|
||
|
|
Number of
units
|
Weighted average
fair value price
|
Number of
units
|
Weighted average
fair value price
|
|
Outstanding,
beginning of period
|
402,868
|
$
8.77
|
34,102
|
$
13.00
|
|
Granted
|
25,145
|
9.79
|
24,450
|
12.23
|
|
Issued as common
stock
|
(7,043
)
|
12.16
|
(35,797
)
|
13.06
|
|
Forfeited
|
(17,203
)
|
8.75
|
-
|
-
|
|
Outstanding, end of
period
|
403,767
|
$
8.73
|
22,755
|
$
12.07
|
|
Outstanding vested,
end of period
|
5,000
|
12.32
|
-
|
-
|
|
|
2019
|
2018
|
|
|
Number of
units
|
Number of
units
|
|
Outstanding,
beginning of period
|
3,223,516
|
1,735,898
|
|
Automatic share
reserve increase
|
1,500,000
|
1,500,000
|
|
Units
granted
|
(25,145
)
|
(24,450
)
|
|
Units
forfeited
|
27,213
|
-
|
|
Units
expired
|
260,417
|
-
|
|
Outstanding, end of
period
|
4,986,001
|
3,211,448
|
|
|
2019
|
2018
|
||
|
|
Number of
warrants
|
Weighted average
exercise price
|
Number of
warrants
|
Weighted average
exercise price
|
|
Outstanding,
beginning of period
|
802,469
|
$
10.74
|
140,667
|
$
12.00
|
|
Issued
|
159,663
|
8.55
|
-
|
-
|
|
Exercised
|
-
|
-
|
-
|
-
|
|
Expired
|
-
|
-
|
-
|
-
|
|
Outstanding, end of
period
|
962,132
|
$
10.38
|
140,667
|
$
12.00
|
|
|
2019
|
|
|
|
Number of
warrants
|
Weighted average
exercise price
|
|
January 15,
2020
|
277,778
|
$
9.32
|
|
January 21,
2020
|
24,691
|
9.32
|
|
October 9,
2020
|
159,663
|
8.55
|
|
February 25,
2021
|
200,000
|
11.00
|
|
February 25,
2021
|
300,000
|
12.00
|
|
Outstanding, end of
period
|
962,132
|
$
10.38
|
|
|
2019
|
2018
|
|
Interest on
long-term debt
|
$
13,070
|
$
13,037
|
|
Interest on
convertible notes
|
117,435
|
-
|
|
Accretion
expense
|
547,562
|
-
|
|
Amortization of
deferred finance costs
|
46,442
|
-
|
|
Revaluation of
warrants
|
8,483
|
-
|
|
Gain on conversion
of November 2018 Notes
|
(232,565
)
|
-
|
|
Other
|
1,422
|
(124
)
|
|
|
$
501,849
|
$
12,913
|
|
|
Three Months Ended May
31,
|
||
|
|
2019
|
2018
|
$
Change
|
|
Revenues
|
$
-
|
$
-
|
$
-
|
|
|
|
|
|
|
Operating
expenses
|
|
|
|
|
Research and
development
|
|
|
|
|
Stock-based
compensation
|
312,435
|
410,213
|
(97,778
)
|
|
Other research and
development
|
685,426
|
655,866
|
29,560
|
|
Total research and
development
|
997,861
|
1,066,079
|
(68,218
)
|
|
|
|
|
|
|
General and
administrative
|
|
|
|
|
Stock-based
compensation
|
618,255
|
775,456
|
(157,201
)
|
|
Other general and
administrative
|
1,284,375
|
1,580,094
|
(295,719
)
|
|
Total general and
administrative
|
1,902,630
|
2,355,550
|
(452,920
)
|
|
|
|
|
|
|
Depreciation and
amortization
|
164,336
|
101,069
|
63,267
|
|
Interest and other
finance costs
|
501,849
|
12,913
|
488,936
|
|
Foreign exchange (gain)
loss
|
(12,126
)
|
(6,081
)
|
(6,045
)
|
|
Total
operating expenses
|
3,554,550
|
3,529,530
|
25,020
|
|
Net
loss
|
(3,554,550
)
|
$
(3,529,530
)
|
$
(25,020
)
|
|
|
Three Months Ended
May 31,
|
|
|
|
2019
|
2018
|
|
Net cash used in
operating activities
|
$
(2,087,353
)
|
$
(2,171,061
)
|
|
Net cash used in
investing activities
|
(995,356
)
|
(592,316
)
|
|
Net cash (used)
provided by financing activities
|
4,253,727
|
(13,514
)
|
|
Effect of exchange
rate changes on cash
|
(32,796
)
|
(17,807
)
|
|
Net (decrease)
increase in cash
|
$
1,138,222
|
$
(2,794,698
)
|
|
|
|
Incorporated by Reference
|
|
||
|
Number
|
Description
|
Form
|
File No.
|
Filing Date
|
Exhibit No.
|
|
Form
of Amendment No. 1 to the January 15, 2019 Note Purchase Agreement,
dated April 4, 2019.
|
8-K
|
001-38301
|
10-Apr-19
|
4.1
|
|
|
Form
of Amendment to 2019 Warrant, dated April 4, 2019.
|
8-K
|
001-38301
|
10-Apr-19
|
4.2
|
|
|
Form
of Amendment and Conversion Agreement, dated April 5,
2019.
|
8-K
|
001-38301
|
10-Apr-19
|
4.3
|
|
|
Form
of Amendment to November 2018 Warrant, dated April 8,
2019.
|
8-K
|
001-38301
|
10-Apr-19
|
4.4
|
|
|
24.1
|
Power
of Attorney (contained on signature page to the previously filed
Annual Report on Form 10-K)
|
10-K
|
000-54768
|
08-May-19
|
24.1
|
|
Certification
of Principal Executive Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
Filed herewith
|
|
|
|
|
Certification
of Principal Financial Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
Filed herewith
|
|
|
|
|
Certification
of Principal Executive Officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|
|
Furnished herewith
|
|
|
|
|
Certification
of Principal Financial Officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|
|
Furnished herewith
|
|
|
|
|
101.INS
|
XBRL
Instance Document
|
|
Filed herewith
|
|
|
|
101.SCH
|
XBRL
Taxonomy Extension Schema Document
|
|
Filed herewith
|
|
|
|
101.CAL
|
XBRL
Taxonomy Extension Calculation Linkbase Document
|
|
Filed herewith
|
|
|
|
101.DEF
|
XBRL
Taxonomy Extension Definition Linkbase Document
|
|
Filed herewith
|
|
|
|
101.LAB
|
XBRL
Taxonomy Extension Label Linkbase Document
|
|
Filed herewith
|
|
|
|
101.PRE
|
XBRL
Taxonomy Extension Presentation Linkbase Document
|
|
Filed herewith
|
|
|
|
Date:
July 8, 2019
|
By:
|
/s/ Daniel Solomita
|
|
|
|
Name:
|
Daniel
Solomita
|
|
|
|
Title:
|
President
and Chief Executive Officer, and Director (Principal Executive
Officer)
|
|
|
|
|
|
|
|
Date:
July 8, 2019
|
By:
|
/s/ Nelson Gentiletti
|
|
|
|
Name:
|
Nelson
Gentiletti
|
|
|
|
Title:
|
Chief
Financial Officer and Treasurer (Principal Accounting Officer and
Principal Financial Officer)
|
|
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|